Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from MarketBeat

Got 1K to Invest? These 3 Stocks Are Still Magnificent Buys

Here are three Magnificent 7 technology stocks that offer great opportunities for investors who have $1,000 to put into the market in 2025

Abbott Laboratories Will Outperform Healthcare Stocks in 2025

Abbott Laboratories Will Outperform Healthcare Stocks in 2025

Johnson & Johnson and Abbott Laboratories offer substantial opportunities for investors, but one is a better buy for total returns in 2025 and 2026.

PepsiCo: 53 Years of Dividend Growth and Still Going Strong

PepsiCo: 53 Years of Dividend Growth and Still Going Strong

PepsiCo's 53-year history of increasing dividends demonstrates its consistent commitment to investors and solidifies its position as a stable Dividend King.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Cash Flow Focus: Thermo Fisher, Energy Transfer, and NetEase

Companies with strong cash flow and a history of impressing Wall Street analysts may make excellent prospects for 2025; TMO, ET, and NTES are three to watch.

Should You Buy the Oil Dip? Top Energy Stocks to Hold Now

As the price of oil has dipped recently, investors are left wondering whether there are any value opportunities in the space. It turns out there are three.

Procter & Gamble Proves It’s No Gamble: Uptrend Remains Strong

Procter & Gamble is a solid blue-chip dividend growth stock on track to increase its distribution in 2025 by mid-single-digits, and its shares are rising.

Market Momentum: 3 Stocks Poised for Significant Breakouts

ONON, RDDT, and AVGO are three stocks from three different sectors, all poised for breakouts, reflecting broader market strength.

inkl

Read news from The Economist, FT, and more,
with one subscription

Kinder Morgan’s Uptrend Is Only Half Over: New Highs Are Coming

Kinder Morgan’s Uptrend Is Only Half Over: New Highs Are Coming

It's a golden time to be an LNG operator like Kinder Morgan, whose business is supported by demand growth and the outlook for favorable policy.

Momentum Builders: 3 Stocks Positioned to Shine This Quarter

Momentum Builders: 3 Stocks Positioned to Shine This Quarter

The transportation and industrial spaces have brought some of the best deals for investors, allowing them to start the first quarter of 2025 on a strong note.

GitLab: AI-Driven DevSecOps Innovation Sets It Apart

GitLab: AI-Driven DevSecOps Innovation Sets It Apart

GitLab's strong AI focus, impressive growth, and strategic partnerships position it as a compelling investment opportunity for the year ahead.

DigitalOcean’s AI Potential: A Game-Changer for Growth

DigitalOcean’s AI Potential: A Game-Changer for Growth

DigitalOcean's outlook is improving and creating a catalyst for this undervalued, underappreciated AI play. Growth has stabilized and is expected to accelerate.

Supercharge Your Portfolio With These 3 Key Stocks

Supercharge Your Portfolio With These 3 Key Stocks

Now that 2025 is underway, investors might want to consider the best potential risk-to-reward ratios in the market to supercharge their portfolios.

Tide Shifts for 3M: How to Profit from the Rally

Tide Shifts for 3M: How to Profit from the Rally

3M stock is melting up on improving results and cash flow. Cash allowed for healthy, reliable dividends and robust buybacks.

Palantir Technologies: Another Stellar Year Ahead for the Stock?

Palantir Technologies: Another Stellar Year Ahead for the Stock?

Palantir Technologies became the S&P 500's top performer in 2024, with its stock surging 340%, however concerns now exist over a stretched valuation.

Get all your
news in one place.

100’s of premium titles.
One news app.

2 ETFs to Maximize Gains With Covered Call Strategies

The ISPY and IQQQ ETFs generate high income yields by executing a daily covered call strategy in the benchmark indexes to collect premiums and dividend yields.

3 Small-Cap Stocks Insiders and Institutions Are Buying

Insiders and institutions bought B&GFoods, Archer Aviation, and Wolfspeed in Q4 2024; are these good stocks to buy for 2025? T

MaxCyte: Building the Future of Cell and Gene Therapy Innovation

MaxCyte's proprietary Flow Electroporation technology enables companies like Vertex and CRISPR Therapeutics to get FDA approved for their gene-editing therapy.

Oracle Announces Game-Changing News for the AI Industry

Oracle had a game-changing year, establishing itself as a leading player in AI infrastructure and services. The growth and dividend outlook is improving.

Get all your
news in one place.

100’s of premium titles.
One news app.

Netflix Adds 19 Million Subscribers, Growth Is Far From Over

Netflix shares surged post earnings after the company posted its largest subscriber gains of all time. Shares of Netflix still show upside in 2025 and beyond.

Tempus AI: A Game-Changer in AI-Powered Healthcare

TEM surged 35% on Tuesday, fueled by the launch of its AI-powered health app Olivia and news of Nancy Pelosi's disclosed call option position in the stock.

Pelosi Bets Big on AI: This Is What You Need to Know

Congressional Whale Nancy Pelosi is in the spotlight, buying significant positions in tech stocks like NVDA and other AI plays.

Mobileye's High Short Interest Signals Squeeze Potential

Mobileye is well-positioned within the autonomous driving industry and can take share while deepening penetration with OEMs globally.

Rivian: Weathering the Storm, Poised for Growth?

Rivian's initial Q4 results, DOE loan, strategic partnerships, and innovative technology position the company for substantial growth in the dynamic EV market.

Avient Stock: Manufacturing Play With Double-Digit Upside

Analysts have recently boosted their outlooks on this stock, mixing their bullish expectations for the manufacturing and transportation sectors.

Ultrasound Weight Loss: GE HealthCare and Novo Nordisk’s Play

GLP-1 drugs have been all the rage for weight loss, but GE Healthcare and Novo Nordisk are working on a non-invasive approach to controlling metabolic functions

1 … 48 49 50 51

People

113,401 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

268,915 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play